{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T15:06:30Z","timestamp":1772031990390,"version":"3.50.1"},"reference-count":147,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017531","name":"Gandhi Institute of Technology and Management","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017531","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"India Ministry of Science & Technology Department of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.humimm.2026.111676","type":"journal-article","created":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T04:51:06Z","timestamp":1769921466000},"page":"111676","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cytotoxic and immunomodulatory activity of CD151-LEL-based peptides in breast cancer and THP-1 cells"],"prefix":"10.1016","volume":"87","author":[{"given":"Rahul Kumar","family":"Vempati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2448-1681","authenticated-orcid":false,"given":"RamaRao","family":"Malla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2026.111676_b0005","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12040916","article-title":"The Landscape of Targeted Therapies in TNBC","volume":"12","author":"Vagia","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.humimm.2026.111676_b0010","doi-asserted-by":"crossref","unstructured":"Singh DD, Yadav DK: TNBC: Potential Targeting of Multiple Receptors for a Therapeutic Breakthrough, Nanomedicine, and Immunotherapy. Biomedicines 2021;9.","DOI":"10.3390\/biomedicines9080876"},{"key":"10.1016\/j.humimm.2026.111676_b0015","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41523-022-00486-y","article-title":"Immunotherapy in triple negative breast cancer: beyond checkpoint inhibitors","volume":"8","author":"Abdou","year":"2022","journal-title":"npj Breast Cancer"},{"key":"10.1016\/j.humimm.2026.111676_b0020","article-title":"Immunoinformatics Approach for Epitope-based Vaccine Design: Key steps for Breast Cancer Vaccine","volume":"12","author":"Prawiningrum","year":"2022","journal-title":"Diagnostics (basel)"},{"key":"10.1016\/j.humimm.2026.111676_b0025","doi-asserted-by":"crossref","first-page":"R70","DOI":"10.1186\/bcr3685","article-title":"Feasibility study of personalized peptide vaccination for metastatic recurrent triple-negative breast cancer patients","volume":"16","author":"Takahashi","year":"2014","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.humimm.2026.111676_b0030","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1111\/cas.14510","article-title":"Early phase II study of mixed 19-peptide vaccine monotherapy for refractory triple-negative breast cancer","volume":"111","author":"Toh","year":"2020","journal-title":"Cancer Sci."},{"key":"10.1016\/j.humimm.2026.111676_b0035","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.1080\/07391102.2020.1797539","article-title":"Vaccine candidate designed against carcinoembryonic antigen-related cell adhesion molecules using immunoinformatics tools","volume":"39","author":"Gupta","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.humimm.2026.111676_b0040","article-title":"The HER2 target for designing novel multi-peptide vaccine against breast cancer using immunoinformatics and molecular dynamic simulation","volume":"43","author":"Firuzpour","year":"2025","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.humimm.2026.111676_b0045","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s13205-022-03140-3","article-title":"A candidate triple-negative breast cancer vaccine design by targeting clinically relevant cell surface markers: an integrated immuno and bio-informatics approach","volume":"12","author":"Kumar","year":"2022","journal-title":"3 Biotech"},{"key":"10.1016\/j.humimm.2026.111676_b0050","doi-asserted-by":"crossref","first-page":"7496","DOI":"10.1074\/jbc.M110.173583","article-title":"Structure-function analysis of tetraspanin CD151 reveals distinct requirements for tumor cell behaviors mediated by \u03b13\u03b21 versus \u03b16\u03b24 integrin","volume":"286","author":"Zevian","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.humimm.2026.111676_b0055","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4137\/BIC.S21847","article-title":"Devi Gt, Badana a, Dasari VR, Malla RR: CD151-a striking Marker for Cancer Therapy","volume":"7","author":"Kumari","year":"2015","journal-title":"Biomark Cancer"},{"key":"10.1016\/j.humimm.2026.111676_b0060","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/labinvest.2013.136","article-title":"CD151 in cancer progression and metastasis: a complex scenario","volume":"94","author":"Sadej","year":"2014","journal-title":"Lab. Invest."},{"key":"10.1016\/j.humimm.2026.111676_b0065","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/ajco.13890","article-title":"CD151 and prostate cancer progression: a review of current literature","volume":"19","author":"Kang","year":"2023","journal-title":"Asia Pac. J. Clin. Oncol."},{"key":"10.1016\/j.humimm.2026.111676_b0070","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1161\/CIRCRESAHA.123.323190","article-title":"CD151 Maintains Endolysosomal Protein Quality to Inhibit Vascular Inflammation","volume":"134","author":"Chen","year":"2024","journal-title":"Circ. Res."},{"key":"10.1016\/j.humimm.2026.111676_b0075","doi-asserted-by":"crossref","first-page":"36991","DOI":"10.1074\/jbc.M205265200","article-title":"Expression of the palmitoylation-deficient CD151 weakens the association of alpha 3 beta 1 integrin with the tetraspanin-enriched microdomains and affects integrin-dependent signaling","volume":"277","author":"Berditchevski","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.humimm.2026.111676_b0080","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1158\/0008-5472.CAN-07-2949","article-title":"CD151 accelerates breast cancer by regulating alpha 6 integrin function, signaling, and molecular organization","volume":"68","author":"Yang","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.humimm.2026.111676_b0085","doi-asserted-by":"crossref","first-page":"6059","DOI":"10.1158\/0008-5472.CAN-09-3497","article-title":"Tetraspanin CD151 regulates transforming growth factor beta signaling: implication in tumor metastasis","volume":"70","author":"Sadej","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.humimm.2026.111676_b0090","first-page":"455","article-title":"CD151 Promotes Cancer Progression in Triple-negative Breast Cancer by Inducing EMT through the MAPK Signaling Pathway","volume":"17","author":"Lv","year":"2025","journal-title":"Breast Cancer (dove Med Press)"},{"key":"10.1016\/j.humimm.2026.111676_b0095","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.220640","article-title":"CD151 regulates expression of FGFR2 in breast cancer cells via PKC-dependent pathways","volume":"131","author":"Sadej","year":"2018","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.humimm.2026.111676_b0100","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.neo.2019.08.005","article-title":"Deletion of tetraspanin CD151 alters the Wnt oncogene-induced mammary tumorigenesis: a cell type-linked function and signaling","volume":"21","author":"Li","year":"2019","journal-title":"Neoplasia"},{"key":"10.1016\/j.humimm.2026.111676_b0105","doi-asserted-by":"crossref","first-page":"38756","DOI":"10.1074\/jbc.M110.145417","article-title":"The tetraspanin CD151 is required for Met-dependent signaling and tumor cell growth","volume":"285","author":"Franco","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.humimm.2026.111676_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2024.106304","article-title":"CD151 identifies an NK cell subset that is enriched in COVID-19 patients and correlates with disease severity","volume":"89","author":"Amarilla-Irusta","year":"2024","journal-title":"J. Infect."},{"key":"10.1016\/j.humimm.2026.111676_b0115","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/MIB.0000000000000621","article-title":"CD151 Regulates T-Cell Migration in Health and Inflammatory Bowel Disease","volume":"22","author":"Zelman-Toister","year":"2016","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.humimm.2026.111676_b0120","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/path.5415","article-title":"The CD151-midkine pathway regulates the immune microenvironment in inflammatory breast cancer","volume":"251","author":"Hayward","year":"2020","journal-title":"J. Pathol."},{"key":"10.1016\/j.humimm.2026.111676_b0125","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.4049\/jimmunol.1302874","article-title":"Tetraspanin CD151 is a negative Regulator of Fc\u03b5RI-Mediated Mast Cell Activation","volume":"195","author":"Abdala-Valencia","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2026.111676_b0130","doi-asserted-by":"crossref","first-page":"41165","DOI":"10.1074\/jbc.M104041200","article-title":"Analysis of the CD151-alpha3beta1 integrin and CD151-tetraspanin interactions by mutagenesis","volume":"276","author":"Berditchevski","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.humimm.2026.111676_b0135","doi-asserted-by":"crossref","first-page":"9230","DOI":"10.1074\/jbc.275.13.9230","article-title":"Direct extracellular contact between integrin alpha(3)beta(1) and TM4SF protein CD151","volume":"275","author":"Yauch","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.humimm.2026.111676_b0140","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1182\/blood-2004-09-3606","article-title":"Endothelial tetraspanin microdomains regulate leukocyte firm adhesion during extravasation","volume":"105","author":"Barreiro","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2026.111676_b0145","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.200004","article-title":"Anti-cancer peptides: classification, mechanism of action, reconstruction and modification","volume":"10","author":"Xie","year":"2020","journal-title":"Open Biol."},{"key":"10.1016\/j.humimm.2026.111676_b0150","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.4014\/jmb.2104.04013","article-title":"Antioxidant activity of Novel Casein-Derived Peptides with Microbial Proteases as Characterized via Keap1-Nrf2 Pathway in HepG2 Cells","volume":"31","author":"Zhao","year":"2021","journal-title":"J. Microbiol. Biotechnol."},{"key":"10.1016\/j.humimm.2026.111676_b0155","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.molimm.2025.05.018","article-title":"Using novel approaches to conjugate peptides of Macrotermes bellicosus and Curcuma longa for targeted intervention of irritable bowl diseases caused by tumor necrosis factor superfamily member 15 (TNFSF15)","volume":"183","author":"Naveed","year":"2025","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.humimm.2026.111676_b0160","article-title":"Cyclodipeptides (CDPs), the enzymatic synthesis, and the potential functional properties to exhibit broad varieties of pharmacological properties\u2014A comprehensive review","volume":"37","author":"Fizza","year":"2025","journal-title":"Italian Journal of Food Science\/rivista Italiana Di Scienza Degli Alimenti"},{"key":"10.1016\/j.humimm.2026.111676_b0165","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/967347","article-title":"Cancer treatment using peptides: current therapies and future prospects","volume":"2012","author":"Thundimadathil","year":"2012","journal-title":"J. Amino Acids"},{"key":"10.1016\/j.humimm.2026.111676_b0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160387","article-title":"Peptides from Tetraspanin CD9 are Potent Inhibitors of Staphylococcus Aureus Adherence to Keratinocytes","volume":"11","author":"Ventress","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.humimm.2026.111676_b0175","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.3390\/ijms19103007","article-title":"Inhibition of Tetraspanin Functions Impairs Human Papillomavirus and Cytomegalovirus Infections","volume":"19","author":"Lelieveld-Fast","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.humimm.2026.111676_b0180","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ebiom.2019.10.025","article-title":"Peptides of tetraspanin oncoprotein CD151 trigger active immunity against primary tumour and experimental lung metastasis","volume":"49","author":"Lin","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.humimm.2026.111676_b0185","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/nrd2659","article-title":"Targeting of tetraspanin proteins\u2013potential benefits and strategies","volume":"7","author":"Hemler","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.humimm.2026.111676_b0190","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1142\/S2737416525500383","article-title":"Designing IL-24-P18 Fusion Protein through Computational Engineering for Targeted Breast Cancer Therapy","volume":"25","author":"Naveed","year":"2026","journal-title":"Journal of Computational Biophysics and Chemistry"},{"key":"10.1016\/j.humimm.2026.111676_b0195","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41523-025-00750-x","article-title":"MammOnc-DB, an integrative breast cancer data analysis platform for target discovery","volume":"11","author":"Karthikeyan","year":"2025","journal-title":"npj Breast Cancer"},{"key":"10.1016\/j.humimm.2026.111676_b0200","doi-asserted-by":"crossref","first-page":"R71","DOI":"10.1186\/gb-2014-15-5-r71","article-title":"A shared transcriptional program in early breast neoplasias despite genetic and clinical distinctions","volume":"15","author":"Brunner","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.humimm.2026.111676_b0205","article-title":"Identification of five Cytotoxicity-Related Genes involved in the Progression of Triple-negative Breast Cancer","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Genet."},{"key":"10.1016\/j.humimm.2026.111676_b0210","first-page":"128","article-title":"Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis","volume":"4","author":"Garcia-Recio","year":"2023","journal-title":"Nat Cancer"},{"key":"10.1016\/j.humimm.2026.111676_b0215","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41523-022-00465-3","article-title":"RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer","volume":"8","author":"Staaf","year":"2022","journal-title":"npj Breast Cancer"},{"key":"10.1016\/j.humimm.2026.111676_b0220","doi-asserted-by":"crossref","first-page":"41165","DOI":"10.1074\/jbc.M104041200","article-title":"Analysis of the CD151\u00b7\u03b13\u03b21 Integrin and CD151\u00b7Tetraspanin Interactions by Mutagenesis","volume":"276","author":"Berditchevski","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.humimm.2026.111676_b0225","series-title":"BcePred: Prediction of Continuous B-Cell Epitopes in Antigenic Sequences using Physico-chemical Properties","first-page":"197","author":"Saha","year":"2004"},{"key":"10.1016\/j.humimm.2026.111676_b0230","doi-asserted-by":"crossref","first-page":"W174","DOI":"10.1093\/nar\/gkv342","article-title":"I-TASSER server: new development for protein structure and function predictions","volume":"43","author":"Yang","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.humimm.2026.111676_b0235","doi-asserted-by":"crossref","first-page":"W384","DOI":"10.1093\/nar\/gkt458","article-title":"GalaxyRefine: Protein structure refinement driven by side-chain repacking","volume":"41","author":"Heo","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.humimm.2026.111676_b0240","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1107\/S0021889892009944","article-title":"PROCHECK: a program to check the stereochemical quality of protein structures","volume":"26","author":"Laskowski","year":"1993","journal-title":"J. Appl. Cryst."},{"key":"10.1016\/j.humimm.2026.111676_b0245","doi-asserted-by":"crossref","first-page":"W407","DOI":"10.1093\/nar\/gkm290","article-title":"ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins","volume":"35","author":"Wiederstein","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.humimm.2026.111676_b0250","series-title":"Computational Drug Discovery and Design","first-page":"101","article-title":"GRAMM Web Server for Protein Docking","author":"Singh","year":"2024"},{"key":"10.1016\/j.humimm.2026.111676_b0255","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/pro.3289","article-title":"PDBsum: Structural summaries of PDB entries","volume":"27","author":"Laskowski","year":"2018","journal-title":"Protein Sci."},{"key":"10.1016\/j.humimm.2026.111676_b0260","article-title":"Anti-breast cancer effects of Pterocarpus soyauxii Taub aqueous extract and its compounds by integrating ADMET, network pharmacology, molecular docking, dynamic simulation, CLC-Pred and pdCSM-Cancer\/PPI approaches, and in vitro validation","volume":"120407","author":"Emmanuel","year":"2025","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.humimm.2026.111676_b0265","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1477-3155-11-18","article-title":"Self-assembled nanoparticles based on modified cationic dipeptides and DNA: novel systems for gene delivery","volume":"11","author":"Panda","year":"2013","journal-title":"J Nanobiotechnology"},{"key":"10.1016\/j.humimm.2026.111676_b0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2020.107681","article-title":"Molecular modeling and invitro study on pyrocatechol as potential pharmacophore of CD151 inhibitor","volume":"100","author":"Akella","year":"2020","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.humimm.2026.111676_b0275","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/jcb.29369","article-title":"ShRNA-mediated matrix metalloproteinase-2 gene silencing protects normal cells and sensitizes cancer cells against ionizing-radiation induced damage","volume":"121","author":"Shailender","year":"2020","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.humimm.2026.111676_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115452","article-title":"Insight into drug sensitizing effect of diallyl disulfide and diallyl trisulfide from Allium sativum L. on paclitaxel-resistant triple-negative breast cancer cells","volume":"296","author":"Marni","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.humimm.2026.111676_b0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2025.114740","article-title":"Silencing CD151 gene in donor triple-negative breast cancer cells attenuates exosome-driven functions of recipient cells","volume":"452","author":"Gugalavath","year":"2025","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.humimm.2026.111676_b0290","doi-asserted-by":"crossref","DOI":"10.1111\/cbdd.14600","article-title":"Quercetin and taxifolin inhibits TMPRSS2 activity and its interaction with EGFR in paclitaxel-resistant breast cancer cells: an in silico and invitro study","volume":"104","author":"Kundrapu","year":"2024","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.humimm.2026.111676_b0295","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00280-024-04709-w","article-title":"Combination of ionizing radiation and 2-thio-6-azauridine induces cell death in radioresistant triple negative breast cancer cells by downregulating CD151 expression","volume":"94","author":"Marni","year":"2024","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.humimm.2026.111676_b0300","doi-asserted-by":"crossref","DOI":"10.1007\/s12013-025-01927-8","article-title":"Sanguinarine and Doxorubicin Inhibit Heat shock Protein HSPA5 and Trigger ER stress in Breast Cancer","author":"Bhamidipati","year":"2025","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.humimm.2026.111676_b0305","doi-asserted-by":"crossref","first-page":"372","DOI":"10.4048\/jbc.2016.19.4.372","article-title":"Lipid Raft Integrity is Required for Survival of Triple negative Breast Cancer Cells","volume":"19","author":"Badana","year":"2016","journal-title":"J. Breast Cancer"},{"key":"10.1016\/j.humimm.2026.111676_b0310","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1073\/pnas.262411399","article-title":"Flexibility and molecular recognition in the immune system","volume":"100","author":"Jimenez","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.humimm.2026.111676_b0315","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12864-020-07303-5","article-title":"Conformational epitope matching and prediction based on protein surface spiral features","volume":"22","author":"Lo","year":"2021","journal-title":"BMC Genomics"},{"key":"10.1016\/j.humimm.2026.111676_b0320","first-page":"855","article-title":"On the theoretical prediction of protein antigenic determinants from amino acid sequences","volume":"46","author":"Hofmann","year":"1987","journal-title":"Biomed. Biochim. Acta"},{"key":"10.1016\/j.humimm.2026.111676_b0325","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1002\/j.1460-2075.1985.tb03843.x","article-title":"Towards assignment of secondary structures by anti-peptide antibodies. Specificity of the immune response to a beta-turn","volume":"4","author":"Schulze-Gahmen","year":"1985","journal-title":"EMBO J."},{"key":"10.1016\/j.humimm.2026.111676_b0330","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.2217\/fon-2020-0224","article-title":"B-cell epitope peptide cancer vaccines: a new paradigm for combination immunotherapies with novel checkpoint peptide vaccine","volume":"16","author":"Kaumaya","year":"2020","journal-title":"Future Oncol."},{"key":"10.1016\/j.humimm.2026.111676_b0335","series-title":"Artificial Immune Systems","first-page":"197","article-title":"BcePred: Prediction of Continuous B-Cell Epitopes in Antigenic Sequences using Physico-chemical Properties","author":"Saha","year":"2004"},{"key":"10.1016\/j.humimm.2026.111676_b0340","doi-asserted-by":"crossref","unstructured":"Banerjee S, Majumder K, Gutierrez GJ, Gupta D, Mittal B: Immuno-informatics approach for multi-epitope vaccine designing against SARS-CoV-2. bioRxiv 2020.","DOI":"10.1101\/2020.07.23.218529"},{"key":"10.1016\/j.humimm.2026.111676_b0345","doi-asserted-by":"crossref","first-page":"9521","DOI":"10.1038\/s41598-022-13442-4","article-title":"Designing of multi-epitope chimeric vaccine using immunoinformatic platform by targeting oncogenic strain HPV 16 and 18 against cervical cancer","volume":"12","author":"Kumar","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.humimm.2026.111676_b0350","doi-asserted-by":"crossref","unstructured":"Zhang J, Tao A: Antigenicity, immunogenicity, allergenicity. Allergy bioinformatics 2015:175.","DOI":"10.1007\/978-94-017-7444-4_11"},{"key":"10.1016\/j.humimm.2026.111676_b0355","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.vaccine.2006.11.014","article-title":"Tuberculosis subunit vaccine development: Impact of physicochemical properties of mycobacterial test antigens","volume":"25","author":"Sable","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.humimm.2026.111676_b0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00894-014-2278-5","article-title":"AllerTOP v. 2\u2014a server for in silico prediction of allergens","volume":"20","author":"Dimitrov","year":"2014","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.humimm.2026.111676_b0365","article-title":"INeo-Epp: a Novel T-Cell HLA Class-I Immunogenicity or Neoantigenic Epitope Prediction Method based on Sequence-Related Amino Acid Features","volume":"2020","author":"Wang","year":"2020","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.humimm.2026.111676_b0370","doi-asserted-by":"crossref","unstructured":"Valor L, de la Torre I: Understanding the immunogenicity concept. Reumatol Clin 2013;9:1.","DOI":"10.1016\/j.reumae.2012.09.001"},{"key":"10.1016\/j.humimm.2026.111676_b0375","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073957","article-title":"In silico approach for predicting toxicity of peptides and proteins","volume":"8","author":"Gupta","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.humimm.2026.111676_b0380","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/978-1-4939-2285-7_7","article-title":"Peptide toxicity prediction","volume":"1268","author":"Gupta","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.humimm.2026.111676_b0385","doi-asserted-by":"crossref","first-page":"W432","DOI":"10.1093\/nar\/gkae298","article-title":"admetSAR3.0: a comprehensive platform for exploration, prediction and optimization of chemical ADMET properties","volume":"52","author":"Gu","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.humimm.2026.111676_b0390","article-title":"Novel Antioxidant Self-Assembled Peptides Extracted from Azumapecten farreri Meat","volume":"13","author":"Zheng","year":"2024","journal-title":"Vitro- and in Silico-Assisted Identification"},{"key":"10.1016\/j.humimm.2026.111676_b0395","first-page":"599","article-title":"Design and development of new inhibitors against breast cancer, Monkeypox and Marburg virus by modification of natural Fisetin via in silico and SAR studies","volume":"70","author":"Akash","year":"2023","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.humimm.2026.111676_b0400","doi-asserted-by":"crossref","unstructured":"Alspach E, Lussier DM, Schreiber RD: Interferon \u03b3 and Its Important Roles in Promoting and Inhibiting Spontaneous and Therapeutic Cancer Immunity. Cold Spring Harb Perspect Biol 2019;11.","DOI":"10.1101\/cshperspect.a028480"},{"key":"10.1016\/j.humimm.2026.111676_b0405","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1745-6150-8-30","article-title":"Designing of interferon-gamma inducing MHC class-II binders","volume":"8","author":"Dhanda","year":"2013","journal-title":"Biol. Direct"},{"key":"10.1016\/j.humimm.2026.111676_b0410","doi-asserted-by":"crossref","first-page":"45","DOI":"10.15171\/bi.2019.06","article-title":"In silico design of a triple-negative breast cancer vaccine by targeting cancer testis antigens","volume":"9","author":"Parvizpour","year":"2019","journal-title":"Bioimpacts"},{"key":"10.1016\/j.humimm.2026.111676_b0415","first-page":"215","article-title":"Computational modeling and validation studies of 3-D structure of neuraminidase protein of H1N1 influenza a virus and subsequent in silico elucidation of piceid analogues as its potent inhibitors","volume":"12","author":"Gupta","year":"2013","journal-title":"EXCLI J."},{"key":"10.1016\/j.humimm.2026.111676_b0420","doi-asserted-by":"crossref","first-page":"11337","DOI":"10.1073\/pnas.1222245110","article-title":"Rational modification of protein stability by targeting surface sites leads to complicated results","volume":"110","author":"Xiao","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.humimm.2026.111676_b0425","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1021\/acs.jcim.9b00403","article-title":"Predicting the Affinity of Peptides to Major Histocompatibility complex Class II by Scoring Molecular Dynamics Simulations","volume":"59","author":"Ochoa","year":"2019","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.humimm.2026.111676_b0430","first-page":"e2124","article-title":"PRODIGY: a Contact-based Predictor of Binding Affinity in Protein-protein Complexes","volume":"7","author":"Vangone","year":"2017","journal-title":"Bio Protoc"},{"key":"10.1016\/j.humimm.2026.111676_b0435","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2217\/imt-2019-0096","article-title":"Toll-like receptors as a therapeutic target in cancer, infections and inflammatory diseases","volume":"12","author":"Fl\u00f3rez-\u00c1lvarez","year":"2020","journal-title":"Immunotherapy"},{"key":"10.1016\/j.humimm.2026.111676_b0440","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.ajt.2024.10.011","article-title":"Major histocompatibility complex and peptide specificity underpin CD8(+) T cell direct alloresponse","volume":"25","author":"Zhang","year":"2025","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2026.111676_b0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113170","article-title":"Recent advance of peptide-based molecules and nonpeptidic small-molecules modulating PD-1\/PD-L1 protein-protein interaction or targeting PD-L1 protein degradation","volume":"213","author":"Pan","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.humimm.2026.111676_b0450","doi-asserted-by":"crossref","first-page":"26405","DOI":"10.1038\/s41598-024-77664-4","article-title":"An in silico approach uncovering the competency of oncolytic human adenovirus 52 for targeted breast cancer virotherapy","volume":"14","author":"Naveed","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.humimm.2026.111676_b0455","doi-asserted-by":"crossref","first-page":"W338","DOI":"10.1093\/nar\/gky356","article-title":"CABS-flex 2.0: a web server for fast simulations of flexibility of protein structures","volume":"46","author":"Kuriata","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.humimm.2026.111676_b0460","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24183293","article-title":"Normal Mode Analysis as a Routine Part of a Structural Investigation","volume":"24","author":"Bauer","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.humimm.2026.111676_b0465","doi-asserted-by":"crossref","first-page":"W271","DOI":"10.1093\/nar\/gku339","article-title":"iMODS: internal coordinates normal mode analysis server","volume":"42","author":"L\u00f3pez-Blanco","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.humimm.2026.111676_b0470","unstructured":"Castiglione F, Bernaschi M: C-immsim: playing with the immune response. Proceedings of the sixteenth international symposium on mathematical theory of networks and systems (MTNS2004), Katholieke Universiteit Leuven Belgium, 2004, p 1."},{"key":"10.1016\/j.humimm.2026.111676_b0475","article-title":"In silico design and in vitro validation of a multi-epitope peptide vaccine targeting triple-negative breast cancer","volume":"15","author":"Zhou","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.humimm.2026.111676_b0480","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.procbio.2017.12.004","article-title":"A novel small molecule inhibitor of CD151 inhibits proliferation of metastatic triple negative breast cancer cell lines","volume":"66","author":"Gavara","year":"2018","journal-title":"Process Biochem."},{"key":"10.1016\/j.humimm.2026.111676_b0485","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/697972","article-title":"Monocytes, peripheral blood mononuclear cells, and THP-1 cells exhibit different cytokine expression patterns following stimulation with lipopolysaccharide","volume":"2013","author":"Schildberger","year":"2013","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.humimm.2026.111676_b0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2023.188898","article-title":"Exploring the role of CD151 in the tumor immune microenvironment: Therapeutic and clinical perspectives","volume":"1878","author":"Malla","year":"2023","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.humimm.2026.111676_b0495","first-page":"104","article-title":"Therapeutic potentials of CD151 shRNA in targeting metastasis of triple negative breast cancer cell line MDA-MB-231","volume":"8","author":"Gayatri Devi","year":"2016","journal-title":"J Cancer Sci Ther"},{"key":"10.1016\/j.humimm.2026.111676_b0500","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11010-015-2459-2","article-title":"Targeting CD151 by lentivirus-mediated RNA interference inhibits luminal and basal-like breast cancer cell growth and invasion","volume":"407","author":"Liu","year":"2015","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.humimm.2026.111676_b0505","first-page":"2","article-title":"Knockdown of CD151 gene expression reduces survival of estrogen receptor positive breast cancer cells","volume":"4","author":"Devi","year":"2017","journal-title":"J Clin Exp Oncol"},{"key":"10.1016\/j.humimm.2026.111676_b0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2020.107681","article-title":"Molecular modeling and in vitro study on pyrocatechol as potential pharmacophore of CD151 inhibitor","volume":"100","author":"Akella","year":"2020","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.humimm.2026.111676_b0515","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1042\/BST0390553","article-title":"Tetraspanin CD151 as a target for antibody-based cancer immunotherapy","volume":"39","author":"Haeuw","year":"2011","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.humimm.2026.111676_b0520","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1158\/0008-5472.CAN-09-4032","article-title":"Disruption of laminin-integrin-CD151-focal adhesion kinase axis sensitizes breast cancer cells to ErbB2 antagonists","volume":"70","author":"Yang","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.humimm.2026.111676_b0525","doi-asserted-by":"crossref","first-page":"21786","DOI":"10.1038\/s41598-024-71533-w","article-title":"Combined knockdown of CD151 and MMP9 May inhibit the malignant biological behaviours of triple-negative breast cancer through the GSK-3\u03b2\/\u03b2-catenin-related pathway","volume":"14","author":"Li","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.humimm.2026.111676_b0530","article-title":"Marine natural compound cyclo (L-leucyl-L-prolyl) peptide inhibits migration of triple negative breast cancer cells by disrupting interaction of CD151 and EGFR signaling","volume":"315","author":"Deepak","year":"2020","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.humimm.2026.111676_b0535","first-page":"2666","article-title":"In silico study suggests potential drugs that target CD151 to treat breast cancer and glioblastoma","volume":"45","author":"Ram\u00edrez-Salinas","year":"2024","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.humimm.2026.111676_b0540","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1038\/labinvest.3700351","article-title":"Pericellular activation of proMMP-7 (promatrilysin-1) through interaction with CD151","volume":"85","author":"Shiomi","year":"2005","journal-title":"Lab. Invest."},{"key":"10.1016\/j.humimm.2026.111676_b0545","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1042\/BJ20071625","article-title":"Probing the interaction of tetraspanin CD151 with integrin alpha 3 beta 1 using a panel of monoclonal antibodies with distinct reactivities toward the CD151-integrin alpha 3 beta 1 complex","volume":"415","author":"Yamada","year":"2008","journal-title":"Biochem. J"},{"key":"10.1016\/j.humimm.2026.111676_b0550","doi-asserted-by":"crossref","first-page":"6314","DOI":"10.18632\/oncotarget.6833","article-title":"Generation and characterization of a tetraspanin CD151\/integrin \u03b16\u03b21-binding domain competitively binding monoclonal antibody for inhibition of tumor progression in HCC","volume":"7","author":"Ke","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.humimm.2026.111676_b0555","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ccr.2008.01.031","article-title":"The inhibition of tumor cell intravasation and subsequent metastasis via regulation of in vivo tumor cell motility by the tetraspanin CD151","volume":"13","author":"Zijlstra","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.humimm.2026.111676_b0560","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1089\/mab.2024.0018","article-title":"Monoclonal Antibodies in Clinical Trials for Breast Cancer Treatment","volume":"44","author":"Shaik","year":"2025","journal-title":"Monoclon Antib Immunodiagn Immunother"},{"key":"10.1016\/j.humimm.2026.111676_b0565","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1002\/cbic.202000407","article-title":"Synthetic Antibody Mimics based on Cancer-Targeting Immunostimulatory Peptides","volume":"22","author":"Descalzi-Montoya","year":"2021","journal-title":"Chembiochem"},{"key":"10.1016\/j.humimm.2026.111676_b0570","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/bip.22879","article-title":"B7H6-derived peptides trigger TNF-\u03b1-dependent immunostimulatory activity of lymphocytic NK92-MI cells","volume":"106","author":"Phillips","year":"2016","journal-title":"Biopolymers"},{"key":"10.1016\/j.humimm.2026.111676_b0575","first-page":"465","article-title":"Peptide mimotopes of oncoproteins as therapeutic agents in breast cancer","volume":"11","author":"Ashok","year":"2003","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.humimm.2026.111676_b0580","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.jconrel.2024.05.020","article-title":"Neoantigens and cancer-testis antigens as promising vaccine candidates for triple-negative breast cancer: delivery strategies and clinical trials","volume":"370","author":"Malla","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.humimm.2026.111676_b0585","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1034\/j.1399-0039.2001.580301.x","article-title":"Differential tissue expression of epitopes of the tetraspanin CD151 recognised by monoclonal antibodies","volume":"58","author":"Geary","year":"2001","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.humimm.2026.111676_b0590","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s00262-008-0655-6","article-title":"HLA ligand profiles of primary renal cell carcinoma maintained in metastases","volume":"58","author":"Stickel","year":"2009","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.humimm.2026.111676_b0595","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077394","article-title":"Large extracellular loop of tetraspanin as a potential vaccine candidate for filariasis","volume":"8","author":"Dakshinamoorthy","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.humimm.2026.111676_b0600","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.vaccine.2013.10.083","article-title":"Evaluating the efficacy of rBmHAT\u03b1c as a multivalent vaccine against lymphatic filariasis in experimental animals and optimizing the adjuvant formulation","volume":"32","author":"Dakshinamoorthy","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.humimm.2026.111676_b0605","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1016\/j.bbrc.2018.06.139","article-title":"The peptide mimicking small extracellular loop domain of CD82 inhibits tumor cell migration, adhesion and induces apoptosis by inhibiting integrin mediated signaling","volume":"503","author":"Luan","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.humimm.2026.111676_b0610","article-title":"Designing, cloning and simulation studies of cancer\/testis antigens based multi-epitope vaccine candidates against cutaneous melanoma: an immunoinformatics approach","volume":"37","author":"Khalid","year":"2024","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.humimm.2026.111676_b0615","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.synbio.2024.03.010","article-title":"Discovering peptides and computational investigations of a multiepitope vaccine target Mycobacterium tuberculosis","volume":"9","author":"Nguyen","year":"2024","journal-title":"Synth. Syst. Biotechnol."},{"key":"10.1016\/j.humimm.2026.111676_b0620","article-title":"Design and immunogenic evaluation of multi-epitope vaccines for colorectal cancer: insights from molecular dynamics and In-Vitro studies","volume":"15","author":"Sun","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.humimm.2026.111676_b0625","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2025.110757","article-title":"Development of a novel multi-epitope vaccine against triple-negative breast cancer targeting A-kinase anchoring protein 3 using bioinformatics","volume":"196","author":"Nafiah","year":"2025","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.humimm.2026.111676_b0630","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1007\/s10989-021-10294-w","article-title":"Implementation of Vaccinomics and In-Silico Approaches to Construct Multimeric based Vaccine against Ovarian Cancer","volume":"27","author":"Sufyan","year":"2021","journal-title":"Int. J. Pept. Res. Ther."},{"key":"10.1016\/j.humimm.2026.111676_b0635","doi-asserted-by":"crossref","first-page":"13398","DOI":"10.1038\/s41598-023-40160-2","article-title":"Molecular docking as a tool for the discovery of molecular targets of nutraceuticals in diseases management","volume":"13","author":"Agu","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.humimm.2026.111676_b0640","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.935375","article-title":"Molecular Modeling of ABHD5 Structure and Ligand Recognition","volume":"9","author":"Shahoei","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.humimm.2026.111676_b0645","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/978-1-4939-7000-1_24","article-title":"Stereochemistry and Validation of Macromolecular Structures","volume":"1607","author":"Wlodawer","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.humimm.2026.111676_b0650","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.molimm.2019.04.030","article-title":"In silico analysis of transmembrane protein 31 (TMEM31) antigen to design novel multiepitope peptide and DNA cancer vaccines against melanoma","volume":"112","author":"Safavi","year":"2019","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.humimm.2026.111676_b0655","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.2174\/1389201017666160914191106","article-title":"Harnessing Bioinformatics for Designing a Novel Multiepitope Peptide Vaccine against Breast Cancer","volume":"17","author":"Mahmoodi","year":"2016","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.humimm.2026.111676_b0660","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1034\/j.1399-0039.2002.590601.x","article-title":"Optimizing vaccine design for cellular processing, MHC binding and TCR recognition","volume":"59","author":"Sette","year":"2002","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.humimm.2026.111676_b0665","doi-asserted-by":"crossref","first-page":"e1792","DOI":"10.1038\/cddis.2015.162","article-title":"T-cell exhaustion in the tumor microenvironment","volume":"6","author":"Jiang","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.humimm.2026.111676_b0670","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2024.101324","article-title":"Cancer vaccines: Target antigens, vaccine platforms and preclinical models","volume":"101","author":"Ruzzi","year":"2025","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.humimm.2026.111676_b0675","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/s41577-022-00707-2","article-title":"A guide to antigen processing and presentation","volume":"22","author":"Pishesha","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.humimm.2026.111676_b0680","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/14760584.2017.1306441","article-title":"Influence of protein fold stability on immunogenicity and its implications for vaccine design","volume":"16","author":"Scheiblhofer","year":"2017","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.humimm.2026.111676_b0685","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1146\/annurev-biodatasci-021920-100259","article-title":"Immunoinformatics: predicting Peptide-MHC Binding","volume":"3","author":"Nielsen","year":"2020","journal-title":"Annu. Rev. Biomed. Data Sci."},{"key":"10.1016\/j.humimm.2026.111676_b0690","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s40259-014-0114-1","article-title":"Peptide-based vaccination and induction of CD8+ T-cell responses against tumor antigens in breast cancer","volume":"29","author":"Harao","year":"2015","journal-title":"BioDrugs"},{"key":"10.1016\/j.humimm.2026.111676_b0695","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s10911-022-09516-8","article-title":"CCND1 Amplification in Breast Cancer -associations with Proliferation, Histopathological Grade, Molecular Subtype and Prognosis","volume":"27","author":"Valla","year":"2022","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"10.1016\/j.humimm.2026.111676_b0700","article-title":"CCND1 Amplification Profiling Identifies a Subtype of Melanoma Associated with Poor Survival and an Immunosuppressive Tumor Microenvironment","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2026.111676_b0705","doi-asserted-by":"crossref","first-page":"13632","DOI":"10.18632\/oncotarget.14621","article-title":"The pentapeptide Gly-Thr-Gly-Lys-Thr confers sensitivity to anti-cancer drugs by inhibition of CAGE binding to GSK3\u03b2 and decreasing the expression of cyclinD1","volume":"8","author":"Kim","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.humimm.2026.111676_b0710","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3389\/fonc.2018.00599","article-title":"CAGE Binds to Beclin1, Regulates Autophagic Flux and CAGE-Derived Peptide Confers Sensitivity to Anti-cancer Drugs in Non-small Cell Lung Cancer Cells","volume":"8","author":"Yeon","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.humimm.2026.111676_b0715","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0960-9822(02)00425-6","article-title":"Inhibition of pRb phosphorylation and cell-cycle progression by a 20-residue peptide derived from p16CDKN2\/INK4A","volume":"6","author":"F\u00e5hraeus","year":"1996","journal-title":"Curr. Biol."},{"key":"10.1016\/j.humimm.2026.111676_b0720","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/eji.200838798","article-title":"Tetraspanins CD37 and CD151 differentially regulate Ag presentation and T-cell co-stimulation by DC","volume":"39","author":"Sheng","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.humimm.2026.111676_b0725","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2023.213283","article-title":"A peptide binding to the tetraspanin CD9 reduces cancer metastasis","volume":"146","author":"Suwatthanarak","year":"2023","journal-title":"Biomater Adv"},{"key":"10.1016\/j.humimm.2026.111676_b0730","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1007\/s10495-009-0397-8","article-title":"Conjugation of doxorubicin to cell penetrating peptides sensitizes human breast MDA-MB 231 cancer cells to endogenous TRAIL-induced apoptosis","volume":"14","author":"Aroui","year":"2009","journal-title":"Apoptosis"},{"key":"10.1016\/j.humimm.2026.111676_b0735","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11010137","article-title":"C-Terminal p53 Palindromic Tetrapeptide Restores Full Apoptotic Function to Mutant p53 Cancer Cells In Vitro and In Vivo","volume":"11","author":"Fine","year":"2023","journal-title":"Biomedicines"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885926000224?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885926000224?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T13:36:04Z","timestamp":1772026564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885926000224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":147,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0198885926000224"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2026.111676","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytotoxic and immunomodulatory activity of CD151-LEL-based peptides in breast cancer and THP-1 cells","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2026.111676","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111676"}}